[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355808-105":59,"doc-detail-355808-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","branched-chain-amino-acid-catabolism-is-potentially-deficient-in-pancreatic-cancer-with-high-neural-invasion","Branched-chain amino acid catabolism is potentially deficient in pancreatic cancer with high-neural invasion","","Elevated plasma branched-chain amino acid (BCAA) levels are linked to impaired hepatic BCAA catabolism, yet the status of BCAA catabolism in pancreatic cancer has been unclear. This study tests whether defective hepatic BCAA utilization drives BCAA elevation in pancreatic cancer, using a murine nerve invasion model and patient data. Increased phosphorylation of hepatic BCKDH indicates an inactive state, with reduced whole-body BCAA flux, muscle degradation, and higher plasma BCAAs; severe neural invasion and stage IV disease correlate with poor prognosis and hepatic BCKDH phosphorylation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/branched-chain-amino-acid-catabolism-is-potentially-deficient-in-pancreatic-cancer-with-high-neural-invasion/355808/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/branched-chain-amino-acid-catabolism-is-potentially-deficient-in-pancreatic-cancer-with-high-neural-invasion/355808.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about pancreatic cancer metabolism?","Question",{"text":112,"@type":113},"It investigates whether defective hepatic BCAA utilization contributes to elevated plasma BCAA levels in pancreatic cancer, especially in the context of neural invasion.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What marker indicates impaired hepatic BCAA catabolism in the study?",{"text":117,"@type":113},"Increased phosphorylation of hepatic branched-chain α-keto acid dehydrogenase (BCKDH), indicating an inactive state.",{"name":119,"@type":110,"acceptedAnswer":120},"How do the findings relate to patients and prognosis?",{"text":121,"@type":113},"Patients with stage III pancreatic cancer and severe neural invasion show high plasma BCAA and reduced muscle mass, while stage IV patients show hepatic BCKDH phosphorylation correlated with poor prognosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355808,1790211855,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nBranched-chain amino acid catabolism is potentially deficient in pancreatic cancer with highneural invasion  \nHiroki Michida1,8, Asami Hagiwara1,8, Yuki Saito1, Noriko Kawasaki1, Mayuka Kanda1, Mika Kawasaki1, Sachise Karakawa1, Hidetaka Suzuki2,3, Masafumi Ikeda4,  \nHideki Makinoshima5,6 & Shuichi Mitsunaga2,4,7􀀍  \nElevated plasma branched-chain amino acid (BCAA) levels are observed in some metabolic disorders, such as obesity and diabetes, due to impaired hepatic BCAA catabolism. In pancreatic cancer, elevated plasma BCAA levels are observed years before diagnosis, possibly due to increased protein degradation. However, the status of BCAA catabolism in pancreatic cancer remains unclear. Here, we hypothesized that defective hepatic BCAA utilization contributes to this elevation in pancreatic cancer, similar to observations in obesity and diabetes. Consistent with our hypothesis, increased phosphorylation of the hepatic BCAA catabolic enzyme, branched-chain α-keto acid dehydrogenase (BCKDH), was observed in a murine nerve invasion model with human pancreatic cancer cells, indicative of an inactive state. Notably, this was associated with reduced whole-body BCAA flux, increased skeletal muscle degradation, and elevated plasma BCAA levels. Patients with stage III pancreatic cancer with severe neural invasion exhibited high plasma BCAA and reduced muscle mass. In addition, patients with stage IV pancreatic cancer showed hepatic BCKDH phosphorylation, which correlated with poor prognosis. Overall, these results suggest the potential existence of impaired BCAA catabolism via hepatic BCKDH downregulation in pancreatic cancer.  \nKeywords Branched-chain amino acid, Branched-chain α keto acid dehydrogenase, Pancreatic cancer, Nerve  \ninvasion  \nBranched-chain amino acids (BCAAs), which consist of valine, leucine, and isoleucine, are essential amino acids not synthesized by humans1. The internal BCAA pool in the body is controlled by the balance among the food supply (mainly protein), digestion, protein breakdown or biosynthesis mediated by gut bacteria, and consumption for protein synthesis or energy generation2. When BCAAs are catabolized for energy generation, they first undergo reversible transamination catalysis to generate their corresponding branched-chain keto acids (BCKAs; consisting of α-ketoisovalerate, α-KIV; α-ketoisocaproate, α-KIC; and α-keto-β-methylvalerate,α-KMV), mediated by BCAA transaminase (BCAT), mainly in peripheral tissues, such as the muscles1 and white adipose tissues3, owing to the limited expression of BCAT in the liver1. Then, BCKAs are transferred to the liver via the circulation and decarboxylated by branched-chain α-keto acid dehydrogenase (BCKDH), a rate-limiting enzyme involved in BCAA catabolism4. BCKDH consists of three subunits (E1, E2, and E3) and is regulated by reversible phosphorylation of the E1 subunit at Ser2935. Under fasting conditions, the activity of BCKDH is increased6, and this is regulated by the phosphorylation of the E1 subunit at Ser2935.  \nBCAA levels in plasma are altered in various disorders. Epidemiological studies have indicated that elevated plasma BCAA levels are associated with insulin resistance in obesity7 and coronary artery disease8. In contrast,  \n1Research Institute for Bioscience Products and Fine Chemicals, Ajinomoto Co., Inc., Kawasaki, Japan. 2Division of Biomarker Discovery, Exploratory Oncology Research & ClinicalTrial Center, National Cancer Center, Kashiwa, Japan.  \n3Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan. 4Department of Hepatobiliaryand Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan. 5Tsuruoka Metabolomics Laboratory, National Cancer Center, Tsuruoka, Japan. 6Division of Translational Informatics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan. 7Division of Biomarker Di","cbCaijJPiuRt84R0","https://ap.wps.com/l/cbCaijJPiuRt84R0","pdf",1832060,12,"English","# Introduction\n## BCAA metabolism and BCKDH regulation\n## Plasma BCAA levels in metabolic disorders and cancer\n# Methods and Study Design\n## Murine nerve invasion model and analyses\n# Results\n## Hepatic BCKDH inactivity and systemic metabolic changes\n## Patient correlations with neural invasion and prognosis\n# Conclusion","[{\"question\":\"What question does the study address about pancreatic cancer metabolism?\",\"answer\":\"It investigates whether defective hepatic BCAA utilization contributes to elevated plasma BCAA levels in pancreatic cancer, especially in the context of neural invasion.\"},{\"question\":\"What marker indicates impaired hepatic BCAA catabolism in the study?\",\"answer\":\"Increased phosphorylation of hepatic branched-chain α-keto acid dehydrogenase (BCKDH), indicating an inactive state.\"},{\"question\":\"How do the findings relate to patients and prognosis?\",\"answer\":\"Patients with stage III pancreatic cancer and severe neural invasion show high plasma BCAA and reduced muscle mass, while stage IV patients show hepatic BCKDH phosphorylation correlated with poor prognosis.\"}]","Branched-chain amino acid catabolism is potentially deficient in pancreatic cancer with high-neural invasion | PDF",1790121111,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f756972086d13c51f71a67fd09d541ab.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e863d58bfe1f1cb85102e99d20d8a17.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4627b96b422853d1c8b42567f09d14f7.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc1aa4b2238bdb2aa3bb2e067e43a5da.webp",980,1287]